Paper - WANFANG MED ONLINE

You Position: Home > Paper

The management of hospital acquired pneumonia in children ( 2010 )

( views:1606, downloads:5982 )

Author:: No author available

Journal Title:: CHINESE JOURNAL OF PEDIATRICS

Issue:: 2

DOI:: 10.3760/cma.j.issn.0578-1310.2011.02.008

Key Word:: No keyword available

Abstract： @@ 目录·前言·定义·流行病学·基础疾病与高危因素·病原学·临床特征·实验室检查·诊断·预防·治疗前言中华儿科杂志编辑委员会和中华医学会儿科学分会呼吸学组于2007年制定了<儿童社区获得性肺炎管理指南>,相对于社区获得性肺炎的是医院获得性肺炎(hospital acquired pneumonia,HAP),虽然从病例数量上后者不及前者,但其是儿童医院内感染的主要疾病,也是儿童住院病死的重要原因.

Reference

[1]李文静,刘翠青,马莉.新生儿呼吸机相关性肺炎病原菌分析[J].2006,21(1).
[2]汪复,朱德妹,胡付品,等.2008年中国CHINET细菌耐药性监测[J].2009,(5).
[3]汪复,朱德妹,胡付品,等.2007年中国CHINET细菌耐药性监测[J].2008,(5).
[4]梅小丽,喻文亮.呼吸机相关性肺炎防治循证医学指南[J].2008,(6).
[5]蔡汝丽,陈巧丽,罗雯,等.院内感染小儿支原体肺炎的治疗与预防[J].2009,(3).
[6]张国英,王献民,何伟,等.重症监护病房2002-2007年呼吸机相关性肺炎病原菌流行分布和耐药监测[J].2009,(4).
[7]王丽,杨永弘,陆权,等.儿科常见革兰阴性杆菌耐药性现状分析[J].2008,(3).
[8]王刚,陈沅,匡风梧,等.我院呼吸机与儿童相关性肺炎的病原菌及耐药分析[J].2007,(4).
[9]武素梅,孟晋华,郑延玲.凝固酶阴性葡萄球菌所致婴幼儿败血症[J].2006,(10).
[10]中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童侵袭性肺部真菌感染诊治指南（2009版）[J].2009,(2).
[11]汪复,朱德妹,胡付品,等.2009年中国CHINET细菌耐药性监测[J].2010,(5).
[12]陆权.呼吸道感染常见细菌病原的变迁及对策[J].2008,(6).
[13]费敏,王选锭.铜绿假单胞菌肺炎的最新进展[J].2006,(4).
[14]鲍丽娟,谢永强,邓秋连.儿童感染鲍曼不动杆菌的调查分析[J].2007,(23).
[15]王丽,杨永弘,陆权,等.儿科产超广谱β内酰胺酶大肠埃希菌耐药的流行特征分析[J].2008,(20).
[16]范炤,王素萍,赵启玉,等.太原地区儿童医院获得性肺炎流行特征及病原学研究[J].2008,(8).
[17]张芳,王丹.新生儿侵袭性真菌感染的诊疗进展[J].2008,(13).
[18]史俊艳,张小江,徐英春,等.2007年中国CHINET鲍曼不动杆菌耐药性监测[J].2009,(3).
[19]谈林华,朱雄凯,俞建根,等.婴儿先天性心脏病术后呼吸机相关性肺炎致病菌及耐药性分析[J].2005,(3).
[20]中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南（试行）（下）[J].2007,(3).
[21]中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南（试行）（上）[J].2007,(2).
[22]陈小东.呼吸机相关肺炎的诊治进展[J].2007,(9).
[23]黄敬孚.侵袭性真菌感染及治疗策略[J].2007,(3).
[24]何礼贤.医院获得性肺炎的发病机制及防治[J].2006,(10).
[25]侯爱红.医院获得性肺炎危险因素分析[J].2002,(10).
[26]董方,张美和,甄景慧.儿童肠球菌菌血症临床特征及致病菌耐药性的探讨[J].2003,(9).
[27]Ramsay G,Harvey M,Dellinger RP,etc.Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008.[J].2008,34(1).
[28]Butler KM.Enterococcal infection in children.[J].2006,17(3).
[29]John E. McGowan,Paresh J. Patel,Kenneth V. Leeper.Epidemiology and Microbiology of Hospital-Acquired Pneumonia[J].2002,23(5).
[30]Kieninger AN,Lipsett PA.Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment.[J].2009,89(2).
[31]Badia JR,Adrover M,Ferrer M,etc.Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients.[J].2004,54(2).
[32]Morrow BM,Argent AC,Jeena PM,etc.Guideline for the diagnosis, prevention and treatment of paediatric ventilator-associated pneumonia.[J].2009,99(4).
[33]Jie Zhao,Hong Tang,Kwang Dong Kim,etc.Hyper innate responses in neonates lead to increased morbidity and mortality after infection[J].2008,105(21).
[34]Yao KH,Yang YH.Streptococcus pneumoniae diseases in Chinese children: Past, present and future.[J].2008,26(35).
[35]Dhainaut JF,Fisher CJ Jr,Ely EW,etc.Efficacy and safety of recombinant human activated protein C for severe sepsis.[J].2001,344(10).
[36]LAURENT HOLZAPFEL,SYLVIE CHEVRET,GUILLAUME MADINIER,etc.Influence of long&hyphen; term oro&hyphen; or nasotracheal intubation on nosocomial maxillary sinusitis and pneumoniaResults of a prospective, randomized, clinical trial[J].1993,21(8).
[37]Morrow BM,Argent AC.A comprehensive review of pediatric endotracheal suctioning: Effects, indications, and clinical practice.[J].2008,9(5).
[38]Foglia E,Meier MD,Elward A.Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.[J].2007,20(3).
[39]Chawla R.Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries.[J].2008,36(4 Suppl.).
[40]Koulenti D,Rello J.Gram-negative bacterial pneumonia: aetiology and management.[J].2006,12(3).
[41]Song JH.Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group.[J].2008,36(4 Suppl.).
[42]Curley MA,Schwalenstocker E,Deshpande JK,etc.Tailoring the Institute for Health Care Improvement 100,000 Lives Campaign to pediatric settings: the example of ventilator-associated pneumonia.[J].2006,53(6).
[43]Chapman RL.Prevention and treatment of Candida infections in neonates.[J].2007,31(1).
[44]Masterton RG,Galloway A,French G.Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.[J].2008,62(1).
[45]Aubas S,Clementi E,Gonzalez J,etc.Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.[J].2003,290(19).
[46]Diekema DJ,Pfaller MA,Kroeger J,etc.In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.[J].2008,46(1).
[47]Curley MA,Harris SK,Fraser KA,etc.State Behavioral Scale: a sedation assessment instrument for infants and young children supported on mechanical ventilation.[J].2006,7(2).
[48]Hall KK,Lyman JA.Updated review of blood culture contamination.[J].2006,19(4).
[49]Carlet J.Defining, treating and preventing hospital acquired pneumonia: European perspective.[J].2009,35(1).
[50]Mentec H,Sollet JP,Dupont H,etc.Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.[J].2001,27(2).
[51]A, Liberati,R, D'Amico,V, Torri,etc.Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care.[J].2004,(1).